chrX-53557457-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031407.7(HUWE1):​c.8161-30C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0441 in 1,149,755 control chromosomes in the GnomAD database, including 3,121 homozygotes. There are 15,489 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.046 ( 321 hom., 1625 hem., cov: 22)
Exomes 𝑓: 0.044 ( 2800 hom. 13864 hem. )

Consequence

HUWE1
NM_031407.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.761

Publications

21 publications found
Variant links:
Genes affected
HUWE1 (HGNC:30892): (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]
MIRLET7F2 (HGNC:31484): (microRNA let-7f-2) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant X-53557457-G-A is Benign according to our data. Variant chrX-53557457-G-A is described in ClinVar as Benign. ClinVar VariationId is 1226397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.279 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HUWE1NM_031407.7 linkc.8161-30C>T intron_variant Intron 59 of 83 ENST00000262854.11 NP_113584.3 Q7Z6Z7-1A0A024R9W5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HUWE1ENST00000262854.11 linkc.8161-30C>T intron_variant Intron 59 of 83 1 NM_031407.7 ENSP00000262854.6 Q7Z6Z7-1

Frequencies

GnomAD3 genomes
AF:
0.0458
AC:
5122
AN:
111891
Hom.:
320
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0112
Gnomad AMI
AF:
0.00146
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.0253
Gnomad EAS
AF:
0.295
Gnomad SAS
AF:
0.0275
Gnomad FIN
AF:
0.0356
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0231
Gnomad OTH
AF:
0.0584
GnomAD2 exomes
AF:
0.0900
AC:
16329
AN:
181518
AF XY:
0.0736
show subpopulations
Gnomad AFR exome
AF:
0.0101
Gnomad AMR exome
AF:
0.308
Gnomad ASJ exome
AF:
0.0242
Gnomad EAS exome
AF:
0.307
Gnomad FIN exome
AF:
0.0394
Gnomad NFE exome
AF:
0.0244
Gnomad OTH exome
AF:
0.0610
GnomAD4 exome
AF:
0.0439
AC:
45588
AN:
1037811
Hom.:
2800
Cov.:
25
AF XY:
0.0446
AC XY:
13864
AN XY:
310725
show subpopulations
African (AFR)
AF:
0.00691
AC:
175
AN:
25326
American (AMR)
AF:
0.297
AC:
10426
AN:
35113
Ashkenazi Jewish (ASJ)
AF:
0.0232
AC:
442
AN:
19038
East Asian (EAS)
AF:
0.347
AC:
10412
AN:
29970
South Asian (SAS)
AF:
0.0290
AC:
1534
AN:
52827
European-Finnish (FIN)
AF:
0.0364
AC:
1438
AN:
39557
Middle Eastern (MID)
AF:
0.00956
AC:
38
AN:
3975
European-Non Finnish (NFE)
AF:
0.0242
AC:
19103
AN:
787837
Other (OTH)
AF:
0.0457
AC:
2020
AN:
44168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1237
2473
3710
4946
6183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
962
1924
2886
3848
4810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0458
AC:
5122
AN:
111944
Hom.:
321
Cov.:
22
AF XY:
0.0476
AC XY:
1625
AN XY:
34144
show subpopulations
African (AFR)
AF:
0.0112
AC:
345
AN:
30882
American (AMR)
AF:
0.196
AC:
2070
AN:
10544
Ashkenazi Jewish (ASJ)
AF:
0.0253
AC:
67
AN:
2646
East Asian (EAS)
AF:
0.294
AC:
1031
AN:
3503
South Asian (SAS)
AF:
0.0261
AC:
70
AN:
2687
European-Finnish (FIN)
AF:
0.0356
AC:
217
AN:
6096
Middle Eastern (MID)
AF:
0.0139
AC:
3
AN:
216
European-Non Finnish (NFE)
AF:
0.0231
AC:
1229
AN:
53157
Other (OTH)
AF:
0.0583
AC:
89
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
152
304
457
609
761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0209
Hom.:
224
Bravo
AF:
0.0612

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.44
DANN
Benign
0.25
PhyloP100
-0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17276588; hg19: chrX-53584418; API